{"meta":{"query_hash":"5a74e414f2eb","filters":{"venue":"Acta Medica Balkanika"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5a74e414f2eb","api":"https://metacan.xera.ac/api/v1/cohort?venue=Acta+Medica+Balkanika"},"results":[{"id":"W4414849918","doi":"10.62792/ut.amb.v10.i19-20.p3043","title":"GENE THERAPY FOR CANCER TREATMENT: CONTEMPORARY APPROACHES AND PRINCIPLES","year":2025,"lang":"en","type":"article","venue":"Acta Medica Balkanika","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Genetic enhancement; Clinical trial; Cancer; Cancer therapy; Cancer treatment; Targeted therapy; Disease","score_opus":0.074647941802135,"score_gpt":0.3330534705824447,"score_spread":0.2584055287803097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414849918","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011316539,0.95903945,0.019170444,0.008093188,0.0007271934,0.00006695116,0.000042729782,0.000079346864,0.011649006],"genre_scores_gemma":[0.015343266,0.9601307,0.015220039,0.0030557874,0.0016435471,0.00024022901,0.00006181311,0.000038266127,0.004266351],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999113,0.00023763634,0.00005805928,0.00013854915,0.00038952194,0.000063294035],"domain_scores_gemma":[0.9995136,0.00020445605,0.000046361627,0.00004873944,0.00013365597,0.000053138156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023247246,0.00074128935,0.001074688,0.0019045405,0.00078961684,0.0026035504,0.0012873895,0.0020760738,0.0022706394],"category_scores_gemma":[0.0008044546,0.00035719617,0.0006052029,0.0013740356,0.004006096,0.0024755297,0.001379155,0.0042548133,0.0015163139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014003327,0.0003220509,0.0005803781,0.0075840447,0.00008878937,0.00047692272,0.00071738247,0.002301514,0.022452807,0.16222964,0.02551808,0.77758825],"study_design_scores_gemma":[0.000030987216,0.0003809387,0.00063954765,0.0016730345,0.000041762327,0.0016331951,0.0002420881,0.0008777007,0.0059944247,0.066218786,0.9222025,0.000064878914],"about_ca_topic_score_codex":0.00097461295,"about_ca_topic_score_gemma":0.0010574829,"teacher_disagreement_score":0.0026035504,"about_ca_system_score_codex":0.0015857054,"about_ca_system_score_gemma":0.0013825243,"threshold_uncertainty_score":0.012294471},"labels":[],"label_agreement":null}]}